...Thank you and good morning, ladies and gentlemen. It is my pleasure to welcome each of you to the 2024 annual shareholders meeting for Summit Therapeutics and to call this meeting to order. Attending this meeting virtually is Deepak Bhandarkar, representing PricewaterhouseCoopers LLP, the independent registered public accounting firm for us for fiscal year 2024, subject to shareholder ratification at this meeting. Finally, from our management team today, we have Dr. Makham Zanganeh, our Chief Executive Officer, President, and member of our Board of Directors; Manmeet Soni, our Chief Operating Officer, Chief Financial Officer, and a member of our Board; and Dave Gancarz, our Chief Business and Strategy Officer. We also have Adam [Fireman], a member of our external counsel team from Baker Hughes settler. Dave Gancarz will act as Secretary of the Meeting, and will advise as to certain procedural items. Dave Gancarz ...